Medical device RFP compliance: the 2026 playbook
The compliance landscape for medical device tenders shifted again in 2026. EU MDR transition deadlines hit, FDA's post-market surveillance requirements expanded, and UKCA marking became mandatory for UK market access. If you're filing tenders this year, here's what changed and what it means for your submissions.
EU MDR: the transition deadline is real
The extended transition period under EU MDR 2017/745 expired for most Class IIa and IIb devices. If your products were relying on MDD certificates, they need MDR conformity assessments now. For tenders in EU member states, this means:
- Every product line needs an MDR-compliant Declaration of Conformity
- Notified Body certificates must reference MDR, not MDD
- Post-market surveillance plans are now a tender evaluation criterion, not just a regulatory filing
Tender authorities are checking. We've seen disqualifications for products that still reference MDD certificates in their compliance matrices.
FDA: post-market surveillance in tender scoring
The FDA's updated guidance on post-market surveillance (PMS) has filtered into procurement criteria. Hospitals and GPOs increasingly require:
- Active PMS plans for all Class II and III devices
- Adverse event history disclosure (MAUDE database cross-reference)
- Cybersecurity patching commitments for connected devices
This is new for tender response teams. PMS used to be a regulatory-only concern. Now it's a competitive differentiator in bid scoring.
UKCA: mandatory marking, new evidence requirements
UKCA marking became fully mandatory in 2026. CE-marked devices can no longer be placed on the UK market without UKCA. For tender responses in the UK:
- UKCA Declaration of Conformity required (CE mark is insufficient)
- UK Approved Body involvement for Class IIa+ devices
- MHRA registration confirmation as supporting evidence
Building a compliance-first tender response
The pattern is clear: regulatory compliance is moving from a checkbox exercise to a scored criterion. The teams that win in 2026 will be the ones that can demonstrate compliance with evidence chains, not just claims. Automated compliance verification — cross-referencing regulatory databases, tracking certificate expiry dates, and generating audit-ready evidence bundles — is becoming table stakes for competitive tender response.